{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:17:42Z","timestamp":1721387862115},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/rti.0b013e318279449b","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:13:05Z","timestamp":1355825585000},"page":"11-24","source":"Crossref","is-referenced-by-count":9,"title":["Oncological Applications of Positron Emission Tomography for Evaluation of the Thorax"],"prefix":"10.1097","volume":"28","author":[{"given":"Thomas C.","family":"Kwee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew A.","family":"Torigian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.12120339","article-title":"Molecular imaging: love it or lose it.","volume":"264","author":"Margulis","year":"2012","journal-title":"Radiology"},{"key":"R2-5-20210210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiol.2452061117","article-title":"Molecular imaging techniques in body imaging.","volume":"245","author":"Margolis","year":"2007","journal-title":"Radiology"},{"key":"R3-5-20210210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-5-20210210","first-page":"309","article-title":"Uber den stoffwechsel der carcinomzelle.","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem Z"},{"key":"R5-5-20210210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12149-007-0061-8","article-title":"Performance profile of FDG-PET and PETCT for cancer screening on the basis of a Japanese Nationwide Survey.","volume":"21","author":"Minamimoto","year":"2007","journal-title":"Ann Nucl Med"},{"key":"R6-5-20210210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12149-011-0511-1","article-title":"Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey.","volume":"25","author":"Murano","year":"2011","journal-title":"Ann Nucl Med"},{"key":"R7-5-20210210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacr.2006.12.003","article-title":"ACR Appropriateness Criteria (R) on Solitary Pulmonary Nodule.","volume":"4","author":"Khan","year":"2007","journal-title":"J Am Coll Radiol"},{"key":"R8-5-20210210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","article-title":"Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.","volume":"285","author":"Gould","year":"2001","journal-title":"JAMA"},{"key":"R9-5-20210210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2967\/jnumed.107.044990","article-title":"A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.","volume":"49","author":"Fletcher","year":"2008","journal-title":"J Nucl Med"},{"key":"R10-5-20210210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12149-011-0530-y","article-title":"The value of 18F-FDG-PETCT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis.","volume":"25","author":"Li","year":"2011","journal-title":"Ann Nucl Med"},{"key":"R11-5-20210210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-138-9-200305060-00009","article-title":"Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.","volume":"138","author":"Gould","year":"2003","journal-title":"Ann Intern Med"},{"key":"R12-5-20210210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology.","volume":"49","author":"Fletcher","year":"2008","journal-title":"J Nucl Med"},{"key":"R14-5-20210210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00259-007-0584-1","article-title":"Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules.","volume":"35","author":"Alkhawaldeh","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-5-20210210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJM200007273430404","article-title":"Preoperative staging of non-small-cell lung cancer with positron-emission tomography.","volume":"343","author":"Pieterman","year":"2000","journal-title":"N Engl J Med"},{"key":"R16-5-20210210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.111.099713","article-title":"Effect of PETCT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.","volume":"53","author":"Gregory","year":"2012","journal-title":"J Nucl Med"},{"key":"R17-5-20210210","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2967\/jnumed.108.056713","article-title":"Relationship between cancer type and impact of PET and PETCT on intended management: findings of the national oncologic PET registry.","volume":"49","author":"Hillner","year":"2008","journal-title":"J Nucl Med"},{"key":"R19-5-20210210","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","article-title":"18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.","volume":"50","author":"Jadvar","year":"2009","journal-title":"J Nucl Med"},{"key":"R20-5-20210210","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00259-010-1713-9","article-title":"A new dimension of FDG-PET interpretation: assessment of tumor biology.","volume":"38","author":"Kwee","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 2","key":"R21-5-20210210","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","article-title":"Causes and consequences of increased glucose metabolism of cancers.","volume":"49","author":"Gillies","year":"2008","journal-title":"J Nucl Med"},{"key":"R22-5-20210210","first-page":"1016","article-title":"Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.","volume":"39","author":"Higashi","year":"1998","journal-title":"J Nucl Med"},{"key":"R23-5-20210210","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2967\/jnumed.108.052712","article-title":"Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PETCT.","volume":"49","author":"Goudarzi","year":"2008","journal-title":"J Nucl Med"},{"key":"R24-5-20210210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00259-011-1934-6","article-title":"Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.","volume":"39","author":"Liao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-5-20210210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.acra.2011.08.020","article-title":"Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PETCT in Stage IV nonsurgical small-cell lung cancer.","volume":"19","author":"Liao","year":"2012","journal-title":"Acad Radiol"},{"key":"R27-5-20210210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiol.12111148","article-title":"Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PETCT in non-small cell lung cancer.","volume":"264","author":"Chen","year":"2012","journal-title":"Radiology"},{"key":"R28-5-20210210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00259-011-2059-7","article-title":"Whole-body metabolic tumour volume of 18F-FDG PETCT improves the prediction of prognosis in small cell lung cancer.","volume":"39","author":"Oh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-5-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/609545","article-title":"Use of FDG-PET in radiation treatment planning for thoracic cancers.","volume":"2012","author":"Shirai","year":"2012","journal-title":"Int J Mol Imaging"},{"key":"R30-5-20210210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PETCT for radiation therapy planning: IAEA expert report 2006-2007.","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"key":"R31-5-20210210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.radonc.2011.06.030","article-title":"Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.","volume":"101","author":"Lin","year":"2011","journal-title":"Radiother Oncol"},{"key":"R32-5-20210210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.09.033","article-title":"Impact of hybrid fluorodeoxyglucose positron-emission tomographycomputed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.","volume":"67","author":"Gondi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-5-20210210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/153303460900800208","article-title":"The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.","volume":"8","author":"Kruser","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"R35-5-20210210","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer.","volume":"46","author":"Nestle","year":"2005","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"R37-5-20210210","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.2967\/jnumed.108.057216","article-title":"Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.","volume":"50","author":"Hicks","year":"2009","journal-title":"J Nucl Med"},{"key":"R38-5-20210210","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1200\/JCO.2010.32.4939","article-title":"Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using (18)Ffluorodeoxyglucose and (18)Ffluorothymidine positron emission tomography.","volume":"29","author":"Zander","year":"2011","journal-title":"J Clin Oncol"},{"key":"R39-5-20210210","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2967\/jnumed.111.094458","article-title":"Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3-deoxy-3-18F-fluorothymidine PET.","volume":"52","author":"Kahraman","year":"2011","journal-title":"J Nucl Med"},{"key":"R40-5-20210210","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00259-011-1838-5","article-title":"Standard uptake value and metabolic tumor volume of 18F-FDG PETCT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.","volume":"38","author":"Huang","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R41-5-20210210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00259-012-2118-8","article-title":"Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.","volume":"39","author":"Kobe","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R42-5-20210210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2967\/jnumed.111.092544","article-title":"18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value.","volume":"53","author":"Bengtsson","year":"2012","journal-title":"J Nucl Med"},{"key":"R43-5-20210210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2967\/jnumed.111.096305","article-title":"Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer.","volume":"53","author":"Lopez Guerra","year":"2012","journal-title":"J Nucl Med"},{"key":"R44-5-20210210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1010-7940(00)00572-8","article-title":"Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma.","volume":"18","author":"Voltolini","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"R45-5-20210210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00259-005-1919-4","article-title":"Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.","volume":"33","author":"Hellwig","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R46-5-20210210","first-page":"1640","article-title":"PETCT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.","volume":"45","author":"Keidar","year":"2004","journal-title":"J Nucl Med"},{"key":"R47-5-20210210","first-page":"1412","article-title":"Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.","volume":"42","author":"Zhuang","year":"2001","journal-title":"J Nucl Med"},{"key":"R49-5-20210210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0212-6982(09)71360-6","article-title":"Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.","volume":"28","author":"Sanz-Viedma","year":"2009","journal-title":"Rev Esp Med Nucl"},{"key":"R50-5-20210210","first-page":"9","article-title":"Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.","volume":"53","author":"Basu","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R51-5-20210210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2967\/jnumed.109.068643","article-title":"Prognostic implication of dual-phase PET in adenocarcinoma of the lung.","volume":"51","author":"Houseni","year":"2010","journal-title":"J Nucl Med"},{"key":"R52-5-20210210","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s002590050593","article-title":"Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.","volume":"26","author":"Hustinx","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"R53-5-20210210","first-page":"1819","article-title":"Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.","volume":"46","author":"Kumar","year":"2005","journal-title":"J Nucl Med"},{"key":"R54-5-20210210","first-page":"1440","article-title":"Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.","volume":"47","author":"Mavi","year":"2006","journal-title":"J Nucl Med"},{"key":"R55-5-20210210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.23226","article-title":"Comparison of triple-negative and estrogen receptor-positiveprogesterone receptor-positiveHER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucosepositron emission tomography imaging parameters: a potentially useful method for disease characterization.","volume":"112","author":"Basu","year":"2008","journal-title":"Cancer"},{"key":"R56-5-20210210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11307-009-0212-5","article-title":"Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.","volume":"11","author":"Mavi","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"R57-5-20210210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000341073","article-title":"The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.","volume":"35","author":"Sohn","year":"2012","journal-title":"Onkologie"},{"key":"R58-5-20210210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2011.03.014","article-title":"Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.","volume":"99","author":"Van Loon","year":"2011","journal-title":"Radiother Oncol"},{"key":"R59-5-20210210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2011.03.013","article-title":"The role of positron emission tomography in management of small cell lung cancer.","volume":"73","author":"Thomson","year":"2011","journal-title":"Lung Cancer"},{"key":"R60-5-20210210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PETCT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.","volume":"13","author":"Basu","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"R61-5-20210210","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ejca.2012.01.016","article-title":"Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.","volume":"48","author":"Kaira","year":"2012","journal-title":"Eur J Cancer"},{"key":"R62-5-20210210","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/JTO.0b013e3182519d96","article-title":"High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.","volume":"7","author":"Kadota","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R63-5-20210210","first-page":"333","article-title":"Clinical implications of 18F-fluorodeoxyglucose positron emission tomographycomputed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.","volume":"27","author":"Abe","year":"2012","journal-title":"Oncol Rep"},{"key":"R64-5-20210210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1272874","article-title":"Update on malignant pleural mesothelioma.","volume":"32","author":"Campbell","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"R65-5-20210210","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-06-097238","article-title":"The role of FDG-PET scans in patients with lymphoma.","volume":"110","author":"Seam","year":"2007","journal-title":"Blood"},{"key":"R66-5-20210210","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkins lymphoma.","volume":"23","author":"Schoder","year":"2005","journal-title":"J Clin Oncol"},{"key":"R67-5-20210210","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00259-010-1469-2","article-title":"Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.","volume":"37","author":"Bodet-Milin","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R68-5-20210210","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","article-title":"Diagnostic and prognostic impact of (18)F-FDG PETCT in follicular lymphoma.","volume":"37","author":"Le Dortz","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R69-5-20210210","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","article-title":"Role of functional imaging in the management of lymphoma.","volume":"29","author":"Cheson","year":"2011","journal-title":"J Clin Oncol"},{"key":"R70-5-20210210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"key":"R71-5-20210210","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors.","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R72-5-20210210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"R73-5-20210210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MNM.0b013e328345b984","article-title":"Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.","volume":"32","author":"Liu","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R74-5-20210210","first-page":"195","article-title":"The role of 18Ffluorodeoxyglucose positron emission tomography in thymic epithelial tumors.","volume":"11","author":"Kaira","year":"2011","journal-title":"Cancer Imaging"},{"key":"R75-5-20210210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12149-010-0455-x","article-title":"18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.","volume":"25","author":"Kaira","year":"2011","journal-title":"Ann Nucl Med"},{"key":"R76-5-20210210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1510\/icvts.2010.236273","article-title":"Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.","volume":"11","author":"El-Bawab","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"suppl 1","key":"R77-5-20210210","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1148\/rg.27si075507","article-title":"FDG PETCT for the detection and evaluation of breast diseases: usefulness and limitations.","volume":"27","author":"Lim","year":"2007","journal-title":"Radiographics"},{"issue":"suppl 1","key":"R78-5-20210210","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1148\/rg.27si075517","article-title":"FDG PET, PETCT, and breast cancer imaging.","volume":"27","author":"Rosen","year":"2007","journal-title":"Radiographics"},{"key":"R79-5-20210210","doi-asserted-by":"crossref","first-page":"W304","DOI":"10.2214\/AJR.11.7130","article-title":"False-positive lesions mimicking breast cancer on FDG PET and PETCT.","volume":"198","author":"Adejolu","year":"2012","journal-title":"Am J Roentgenol"},{"key":"R80-5-20210210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jjco\/hyn019","article-title":"Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomographycomputed tomography fusion imaging (18F-FDG PETCT) in primary breast cancer.","volume":"38","author":"Ueda","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"R81-5-20210210","doi-asserted-by":"crossref","first-page":"W247","DOI":"10.2214\/AJR.11.6478","article-title":"Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.","volume":"197","author":"Wang","year":"2011","journal-title":"Am J Roentgenol"},{"key":"R82-5-20210210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12149-011-0556-1","article-title":"Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.","volume":"26","author":"Kim","year":"2012","journal-title":"Ann Nucl Med"},{"key":"R83-5-20210210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.breast.2011.07.002","article-title":"FDG-PETCT in the staging of localregional metastases in breast cancer.","volume":"20","author":"Robertson","year":"2011","journal-title":"Breast"},{"key":"R84-5-20210210","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00259-012-2181-1","article-title":"Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.","volume":"39","author":"Vinh-Hung","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R85-5-20210210","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","article-title":"The yield of 18F-FDG PETCT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.","volume":"52","author":"Groheux","year":"2011","journal-title":"J Nucl Med"},{"key":"R86-5-20210210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00259-012-2077-0","article-title":"Whole-body FDG PETCT is more accurate than conventional imaging for staging primary breast cancer patients.","volume":"39","author":"Riegger","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R87-5-20210210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1634\/theoncologist.2011-0089","article-title":"FDG-PETCT compared with conventional imaging in the detection of distant metastases of primary breast cancer.","volume":"16","author":"Niikura","year":"2011","journal-title":"Oncologist"},{"key":"R88-5-20210210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00259-010-1626-7","article-title":"Tumour markers and FDG PETCT for prediction of disease relapse in patients with breast cancer.","volume":"38","author":"Evangelista","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R89-5-20210210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdq343","article-title":"Positron emission tomographycomputed tomography in the management of recurrentmetastatic breast cancer: a large retrospective study from the Royal Marsden Hospital.","volume":"22","author":"Constantinidou","year":"2011","journal-title":"Ann Oncol"},{"key":"R90-5-20210210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2967\/jnumed.111.094045","article-title":"Triple-negative breast cancer: early assessment with 18F-FDG PETCT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.","volume":"53","author":"Groheux","year":"2012","journal-title":"J Nucl Med"},{"key":"R91-5-20210210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2008.02.004","article-title":"Comparison of FDG-PETCT and CT for delineation of lumpectomy cavity for partial breast irradiation.","volume":"71","author":"Ford","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R92-5-20210210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ijrobp.2011.10.040","article-title":"Pretreatment staging positron emission tomographycomputed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.","volume":"83","author":"Walker","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R93-5-20210210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0019-509X.62998","article-title":"Non-FDG PET in the practice of oncology.","volume":"47","author":"Caroli","year":"2010","journal-title":"Indian J Cancer"},{"key":"R94-5-20210210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.110.075663","article-title":"Molecular imaging of hypoxia.","volume":"52","author":"Chitneni","year":"2011","journal-title":"J Nucl Med"},{"key":"R95-5-20210210","first-page":"253","article-title":"Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.","volume":"46","author":"Eschmann","year":"2005","journal-title":"J Nucl Med"},{"key":"R96-5-20210210","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2012.43.1858","article-title":"Timing of epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung cancer with EGFR mutations.","volume":"30","author":"Moran","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"R97-5-20210210","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis.","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"R98-5-20210210","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.100842","article-title":"PET of EGFR expression with an 18F-labeled affibody molecule.","volume":"53","author":"Miao","year":"2012","journal-title":"J Nucl Med"},{"key":"R99-5-20210210","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68GaDOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"R100-5-20210210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2967\/jnumed.109.066662","article-title":"Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors.","volume":"51","author":"Campana","year":"2010","journal-title":"J Nucl Med"},{"key":"R101-5-20210210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2967\/jnumed.109.071712","article-title":"68Ga-DOTANOC PETCT clinical impact in patients with neuroendocrine tumors.","volume":"51","author":"Ambrosini","year":"2010","journal-title":"J Nucl Med"},{"key":"R102-5-20210210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMp1114866","article-title":"Preparing for precision medicine.","volume":"366","author":"Mirnezami","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Journal of Thoracic Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RTI.0b013e318279449b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:44:01Z","timestamp":1621885441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005382-201301000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rti.0b013e318279449b","relation":{},"ISSN":["0883-5993"],"issn-type":[{"value":"0883-5993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}